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Abstract 
Background 
There is increasing interest in the role of ‘self-management’ interventions to support the 
management of long-term conditions in health service settings. Self-management may 
include patient education, support for decision-making, self-monitoring and psychological 
and social support. Self-management support has potential to improve the efficiency of health 
services by reducing other forms of utilisation (such as primary care or hospital use), but a 
shift to self-management may lead to negative outcomes, such as patients who feel more 
anxious about their health, are less able to cope, or who receive worse quality of care, all of 
which may impact on their health and quality of life. We sought to determine which models 
of self-management support are associated with significant reductions in health services 
utilisation without compromising outcomes among patients with long-term conditions. 
Methods 
We used systematic review with meta-analysis. We included RCTs in patients with long-term 
conditions which included self-management support interventions and reported measures of 
service utilisation or costs, as well as measures of health outcomes (standardized disease 
specific quality of life, generic quality of life, or depression/anxiety).We searched multiple 
databases (CENTRAL, CINAHL, Econlit, EMBASE, HEED, MEDLINE, NHS EED and 
PsycINFO) and the reference lists of published reviews. We calculated effects sizes for both 
outcomes and costs, and presented the results in permutation plots, as well as conventional 
meta-analyses. 
Results 
We included 184 studies. Self-management support was associated with small but significant 
improvements in health outcomes, with the best evidence of effectiveness in patients with 
diabetic, respiratory, cardiovascular and mental health conditions. Only a minority of self-
management support interventions reported reductions in health care utilisation in association 
with decrements in health. Evidence for reductions in utilisation associated with self-
management support was strongest in respiratory and cardiovascular problems. Studies at 
higher risk of bias were more likely to report benefits. 
Conclusions 
Self-management support interventions can reduce health service utilization without 
compromising patient health outcomes, although effects were generally small, and the 
evidence was strongest in respiratory and cardiovascular disorders. Further work is needed to 
determine which components of self-management support are most effective. 
Keywords 
Self-management support interventions, Long-term conditions, Health outcomes, Quality of 
life, Health care utilization, Hospitalizations, Costs, Cost-effectiveness, Systematic review, 
Meta-analysis 
Background 
With the increasing prevalence of long-term conditions [1], and with many patients reporting 
multimorbidity [2], there is worldwide interest in innovations in service delivery that can 
better manage these patients [3]. The global financial crisis and subsequent constraint on 
spending has led to a shift in focus to more efficient models of care which can reduce high 
cost service use such as emergency hospital admissions. This has in turn led to a focus on 
patients at high risk of high utilisation, with the introduction of algorithms to identify those 
patients and complex case management interventions to manage them. However, evidence of 
the effectiveness of this approach is limited [4], and recent commentators have highlighted 
that a focus on very high risk cases limits impact, because they account for only a small 
proportion of overall health care use [5]. 
This has increased interest in the wider group of patients with long-term conditions. It has 
been suggested that many patients with long-term conditions can be managed effectively by 
effective support for ‘self-management’. Self-management has been defined as ‘the care 
taken by individuals towards their own health and well being: it comprises the actions they 
take to lead a healthy lifestyle; to meet their social, emotional and psychological needs; to 
care for their long-term condition; and to prevent further illness or accidents’, and can include 
responding to symptoms, managing acute episodes, relaxation, exercise and smoking 
cessation, managing the emotional impact of conditions, and working effectively with health 
professionals and other community resources [6]. Self-management support in the United 
Kingdom National Health Service is provided through various platforms, including 
increasing access to health information [7], deployment of assistive technologies such as 
telehealth and telecare [8,9]; community based skills-training and support networks [10-12], 
and interventions led by health professionals [13]. 
Self-management and demand management 
A key driver of the interest in self-management is the potential to make a significant 
contribution to efficient health care delivery [14], by increasing patient engagement in care, 
improving uptake of preventive activities, and reducing reliance on formal health care 
services by better management of existing conditions. However, the scale of the contribution 
of self-management to the management of demand is unclear. Positive reports of impacts of 
self-management support on health care utilisation [15] have not always been replicated [16], 
and some self-management interventions may increase demand [17]. 
In economic terms, efficiency involves maximising outcomes for a given cost or minimising 
costs for a given level of outcome. When interventions improve outcomes and increase costs 
(see Figure 1), decision-makers are faced with decisions about ‘allocative efficiency’, where 
additional resources are needed for a new service, which may incur opportunity costs for 
other groups of patients [18]. However, in the context of financial pressures, there may be 
equal interest in the interventions which are less costly and at least as effective as current 
treatments (known as ‘technically efficient’ interventions) [18]. There is an implicit 
assumption that self-management support has the potential to be technically efficient. This 
may occur by patients undertaking care traditionally done by health professionals (for 
example, monitoring of blood pressure), or by better management of long-term conditions, 
which enables complications and crises (and subsequent hospital admission) to be avoided. 
Figure 1 PRISMA flow diagram. 
However, increasing self-management is not uncomplicated. If patients are poorly prepared 
for new roles, they may suffer negative outcomes. Increasing the role of patients in the 
management of long-term conditions, while reducing access to formal services, may result in 
anxiety, coping difficulties, and reduced quality of care. Achieving cost savings while 
significantly reducing patient quality of life would be a poor outcome for health services and 
patients. 
The research question underlying this review was: What models of self-management support 
are associated with significant reductions in health services utilisation without compromising 
outcomes, among patient with long-term conditions? 
Methods 
The review protocol is available as part of the PROSPERO database (registration number: 
CRD42012002694). Minor deviations from the published protocol were made in data 
extraction procedures because of the large number of studies identified by the review. 
Population 
We included studies of patients with a long-term condition, defined generically as ‘one that 
cannot be cured but can be managed through medication and/or therapy.’ This included 
common physical conditions such as diabetes, asthma, coronary heart disease, and mental 
health conditions such as depression. We also included studies recruiting patients with a mix 
of long-term conditions, and those recruiting on the basis of multimorbidity. We excluded 
subjects under 18 years of age, and studies conducted in the developing world. 
Intervention 
For the purposes of the review, we defined a self-management support intervention as: 
‘An intervention primarily designed to develop the abilities of patients to undertake 
management of health conditions through education, training and support to develop patient 
knowledge, skills or psychological and social resources’ 
We included all formats and delivery methods (group or individual, face to face or remote, 
professional or peer led). We included all studies which included a significant component of 
self-management support. After initial screening of a proportion of the studies, we 
distinguished 2 categories: 
• ‘Self-management’ including provision of materials and support from a health professional 
or trained peer. We coded the amount of support as in three categories for descriptive 
purposes: ‘pure’ self-management (no support), ‘supported self-management’ (up to 2 
hours of additional support for the total durationof the study) and ‘intensively supported 
self-management’ (more than 2 hours of additional support) 
• ‘Case management’ (with more than 2 hours of additional support, and including input 
from a multidisciplinary team) 
Two authors independently assessed the type of intervention and disagreements were 
resolved via discussion. 
Comparisons 
We included studies where the self-management support intervention was compared against 
usual care alone, or where the self-management support intervention was compared against a 
more intensive ‘usual care’ intervention (e.g. self-management versus conventional hospital 
use). We excluded studies where two versions of self-management support interventions were 
compared as such comparisons did not allow assessment of the impact of the self-
management support per se. 
Outcomes 
We extracted data on core types of health care utilisation, with a focus on comprehensive 
measures (i.e. cost summaries including multiple sources of utilisation) or major cost drivers 
(i.e. hospital use). Other, more minor costs (such as medication and primary care visits) were 
identified but not analysed. We also separately extracted data on outcomes relating to patient 
quality of life and health outcomes, including standardised measures of disease specific 
quality of life outcomes, generic quality of life, and depression/anxiety. We excluded 
measures of psychological or clinical variables which did not provide a direct assessment of 
health or quality of life, such as self-management behaviour, self-efficacy, HbA1C or forced 
expiratory volume (FEV), as these are likely to be unreliable indicators of health related 
quality of life [19]. 
Study design 
We restricted the review to randomised controlled trials 
Identification of studies 
We conducted a primary search of multiple databases in June 2012. Databases included the 
CENTRAL register of controlled trials, CINAHL, Econlit, EMBASE, HEED, MEDLINE, 
MEDLINE in process, NHS EED and PsycINFO. An example search is listed in Additional 
file 1. We also identified eligible studies by checking published reviews (listed in Additional 
file 1). 
Titles and abstracts were screened for eligibility. More than 40% of titles and abstracts (n = 
5,000) were screened by 2 researchers independently (kappa = 0.87). Screening of the 
remaining titles and abstracts was completed by one reviewer. Approximately one third of the 
full texts were screened by 2 reviewers independently (kappa = 0.85), with the remaining 
full-texts screened by one reviewer. The studies had to fulfil five inclusion criteria to be 
eligible for inclusion in the review: 
• Randomised controlled trials 
• Diagnosis of a long-term condition 
• Self-management or case management intervention 
• Adults (aged ≥ 18 years) 
• Report quantitative data on health care utilization (hospitalization rates/costs and total 
costs) and health outcomes (quality of life, depression and anxiety). Studies reporting non-
amenable data for meta-analysis on both, health outcomes and health care utilization, were 
excluded from the review. 
Data extraction 
Descriptive data on studies, populations and interventions were extracted by 2 researchers 
working independently. A subset of data on quantitative outcomes (n = 50) were extracted by 
2 members of the research team working independently, with the rest of the data extracted by 
one member and checked by a second. 
We extracted data on the effect of self-management interventions on health care utilisation 
and total costs. To assess study quality, we chose a dichotomous measure based on allocation 
concealment, as this is consistently associated with treatment effect [20,21]. Allocation 
concealment was judged as adequate or inadequate according to the Cochrane risk of bias 
tool. We analysed outcomes, grouping by risk of bias to assess whether results varied by 
study quality. 
Analyses 
We calculated standardised mean differences for health outcomes and costs using reported 
data or appropriate transformation and imputation [22]. Some measures of utilisation (e.g. 
hospital length of stay) and costs demonstrate significant skew. In line with published 
reviews, we identified those outcomes where the standard deviation multiplied by two was 
greater than the mean, as this indicates that the mean is not a good indicator of the centre of 
the distribution [23,24], although skewed data are less problematic if the sample size is large. 
Cluster trials were identified and the precision of analyses adjusted using a sample 
size/variation inflation method [25], assuming an intra-class correlation of 0.02. Studies 
reporting multiple self-management interventions were treated as separate comparisons, with 
appropriate adjustment of sample sizes to avoid double counting. We explored statistical 
heterogeneity through the I2 statistic [26], labelling levels of heterogeneity as ‘low’ (0%-
25%), ‘moderate’ (26-74%) and ‘high’ (75%+). 
We present the results of the included studies according to a permutation plot [27]. This 
involves plotting the effect of interventions on utilisation and outcomes simultaneously and 
placing them in quadrants of the cost effectiveness plane depending on the pattern of 
outcomes. Such plots identify studies in the appropriate quadrant (i.e. those that reduce costs 
without compromising outcomes) and those in problematic quadrants (i.e. those that reduce 
costs but also compromise outcomes, or those that compromise both outcomes and costs). 
Hospital use generally represents a significant driver of total costs, but limiting analysis to a 
single cost source leaves the analysis vulnerable to cost shifting, where benefits found in 
terms of reductions in hospital use mask increases in costs elsewhere (e.g. to primary care, or 
patient out of pocket costs). We presented two permutation plots, one based on studies 
reporting a measure related to hospital use, and one based on total costs. 
For each condition, we conducted separate meta-analyses of the effects of self-management 
interventions in trials reporting utilisation outcomes (separately for total costs and hospital 
use outcomes) and in trials reporting health outcomes. We conducted secondary analyses, 
exploring differences by study quality (high and low risk of bias) and country of origin (UK 
versus non-UK). 
As a secondary analysis, we then identified the subset of trials of self-management 
interventions reporting both utilisation and health outcomes, and conducted a meta-analysis 
of the effects of self-management interventions on utilisation and health outcomes, in this 
subset of trials. We conducted these sensitivity analyses in those long-term conditions where 
there were at least 10 studies with both outcomes. We repeated each of these analyses, 
distinguishing self-management and case management, as defined previously. 
We created funnel plots [28] using standard errors [29] (with associated regression tests) to 
assess the potential for small sample bias for each outcome. 
Results 
Study characteristics 
The PRISMA diagram is shown in Figure 1, with study references listed in Additional file 1. 
A completed PRISMA checklist is listed in Additional file 2. Descriptive characteristics of 
the studies are provided in Table 1. 
  
Table 1 Basic descriptive data on the studies 
Category Characteristics N (n = 184) 
Context Country  
     UK 43 (23%) 
     US 65 (35%) 
     European 44 (24%) 
     Other 32 (17%) 
Patients Condition  
     Arthritis 14 (8%) 
     Cardiovascular 53 (29%) 
     Diabetes 11 (6%) 
     Mental health 29 (16%) 
     Mixed disease 13 (7%) 
     Respiratory 44 (24%) 
     Pain 20 (11%) 
     Mean Age (SD) 58 (13) 
     % Male 49% 
Intervention Content  
     Pure SM 9 (5%) 
     Supported SM 36 (20%) 
     Intensive SM 87 (47%) 
     Case management 52 (28%) 
 Sample size (SD) 275 (272) 
 Range 23-1801 
External validity Excluded patients with other long-term conditions 65 (35%) 
 Proportion of eligible patients who did not take part in the study 
 Not clear 48 (26%) 
 <20% 40 (22%) 
 21-40% 55 (30%) 
 41-60% 25 (14%) 
 61-80% 14 (8%) 
 81-100% 2 (1%) 
Relationships between cost and health outcomes 
Figures 2 and 3 show the overall permutation plots, plotting health outcomes and hospital use 
outcomes (Figure 2) and health outcomes and costs (Figure 3). In terms of hospital use, the 
bulk of studies are in the lower right quadrant (i.e. they are associated with improvements in 
health outcomes and reductions in utilisation). Only a minority of studies report decrements 
in health outcomes, and a smaller proportion of studies report improved outcomes with 
increases in utilisation. In terms of costs, the picture is more mixed, with more studies in the 
top right quadrant, reporting improved outcomes with increases in costs. Note that the plots 
do not represent the uncertainty around point estimates, which in many studies would be 
considerable. Of the 71 studies reporting costs, almost all demonstrated significant skew (i.e. 
the standard deviation multiplied by 2 was more than twice the mean). 
Figure 2 Permutation plot – Health outcomes and hospital use outcomes. 
Figure 3 Permutation plot – Health outcomes and total costs. 
Effects of self-management support on health outcomes and utilisation 
Table 2 shows the impact of self-management support on hospital use and health outcomes, 
structured by type of long-term condition and type of self-management support. Results are 
highlighted in the table that show an effect size of 0.2 (at least a ‘small’ effect by current 
convention), where the effect is also statistically significant. As can be seen from Table 2, 
such impacts are found in a number of cells in relation to health outcomes, but are restricted 
to interventions in respiratory and cardiovascular populations in relation to hospital use. 
Table 2 Summary – hospital use (overall ES, 95% CI, N, I2) 
 Combined QoL Self-management QoL Case management QoL Combined hospital use Self-management hospital use Case management hospital use 
Respiratory 0.27 0.28 0.19 −0.21 −0.19 −0.26 
(0.16 to 0.37, n = 34, moderate) (0.16 to 0.41, n = 27, moderate) (0.02 to 0.36, n = 7, low) (−0.32 to −0.09, n = 31, moderate) (−0.33 to −0.05, n = 25, moderate) (−0.42 to −0.10, n = 6, zero) 
Cardiac 0.21 0.19 0.26 −0.23 −0.20 −0.29 
(0.14 to 0.28, n = 40, moderate) (0.10 to 0.27, n = 27, moderate) (0.12 to 0.39, n = 13, moderate) (−0.34 to −0.13, n = 38, high) (−0.33 to −0.07, n = 25, high) (−0.47 to −0.11, n = 13, high) 
Arthritis 0.16 0.17 0.13 −0.06 −0.02 −0.24 
(0.07 to 0.26, n = 11, zero) (0.07 to 0.27, n = 7, zero) (−0.13 to 0.39, n = 4, zero) (−0.22 to 0.10, n = 6, moderate) (−0.19 to 0.16, n = 5, moderate) (−0.48 to 0.00, n = 1, NA) 
Pain 0.13 0.12 0.20 −0.03  −0.03 
(0.04 to 0.21, n = 19, low) (0.02 to 0.22, n = 15, low) (−0.10 to 0.50, n = 4, zero) (−0.34 to 0.28, n = 3, low)  (−0.34 to 0.28, n = 3, low) 
Diabetes 0.44 0.44  −0.12 −0.12  
(0.14 to 0.75, n = 10, high) (0.14 to 0.75, n = 10, high)  −0.29 to 0.05, n = 5, moderate) −0.29 to 0.05 n = 5, moderate)  
Mental health 0.22 0.05 0.38 −0.03 −0.03 −0.04 
(0.11 to 0.33, n = 26, high) (−0.07 to 0.17, n = 15, moderate) (0.24 to 0.51, n = 11, high) (−0.10 to 0.04, n = 21, low) (−0.16 to 0.10, n = 13, moderate) (−0.13 to 0.05, n = 8, zero) 
Mixed 0.13 0.11 0.22 −0.12 −0.09 −0.13 
(0.02 to 0.24, n = 10, moderate) (−0.03 to 0.24, n = 7, moderate) (−0.03 to 0.48, n = 3, moderate) (−0.20 to −0.03, n = 11, moderate) (−0.17 to −0.02, n = 8, zero) (−0.40 to 0.14, n = 3, moderate) 
Bold letters: > =0.2 and statistically significant effects.
Table 3 is structured in the same way, but details the impact of self-management support on 
costs and health outcomes. The patterns are broadly similar, although effects are now 
reported for arthritis and pain, but restricted to case management interventions. It should be 
noted that some of the differences between Tables 2 and 3 reflect changes in the number of 
studies included in the analysis and associated precision of the estimates. 
Table 3 Summary – costs (overall ES, 95% CI, N, I2) 
 Combined QoL Self-management QoL Case management QoL Combined costs Self-management costs Case management costs 
Respiratory 0.27 0.28 0.19 0.09 0.09 0.09 
(0.16 to 0.37, n = 34, moderate) (0.16 to 0.41, n = 27, moderate) (0.02 to 0.36, n = 7, low) (−0.14 to 0.33, n = 9, high) (−0.19, 0.37) N = 6, high) (−0.46 to 0.64, n = 3, high) 
Cardiac 0.21 0.19 0.26 −0.25 −0.25 −0.27 
(0.14 to 0.28, n = 40, moderate) (0.11 to 0.27, n = 27, moderate) (0.12 to 0.39, n = 13, moderate) (−0.47 to −0.04, n = 9, moderate) (−0.82, 0.32, n = 4, high) (−0.44, −0.10, n = 5, moderate) 
Arthritis 0.16 0.17 0.13 0.07 0.14 −0.28 
(0.07 to 0.26, n = 11, zero) (0.07 to 0.27, n = 7, zero) (−0.13 to 0.39, n = 4, zero) (−0.07 to 0.20, n = 11, moderate) (0.01 to 0.27, n = 8, moderate) (−0.53 to −0.03, n = 3, zero) 
Pain 0.13 0.12 0.20 0.07 0.15 −0.41 
(0.04 to 0.21, n = 19, zero) (0.02 to 0.22, n = 15, low) (−0.11 to 0.51, n = 4, zero) (−0.13 to 0.28, n = 13, high) (−0.06 to 0.36, n = 11, high) (−0.74 to −0.08), n = 2, zero) 
Diabetes 0.44 0.44  0.19 0.19  
(0.14 to 0.75, n = 10, high) (0.14 to 0.75, n = 10, high)  (−0.18, 0.55, n = 4, moderate) (−0.18, 0.55, n = 4, moderate)  
Mental health 0.22 0.05 0.38 0.03 −0.04 0.05 
(0.11 to 0.33, n = 26, high) (−0.07 to 0.17, n = 15, moderate) (0.24 to 0.51, n = 11, high) (−0.05 to 0.11, n = 14, low) (−0.23 to 0.15, n = 4, moderate) (−0.04 to 0.13, n = 10, low) 
Mixed 0.13 0.11 0.22 0.06 0.05 0.11 
(0.02 to 0.24, n = 10, moderate) (−0.03 to 0.24, n = 7, moderate) (−0.03 to 0.48, n = 3, low) (−0.02 to 0.13, n = 7, zero) (−0.04 to 0.13, n = 6, zero) (−0.09 to 0.31, n = 1, N/A) 
Bold letters: > =0.2 and statistically significant effects.
The sensitivity analyses (not shown) showed similar patterns of results when analyses are 
restricted to the subset of studies which report both health outcomes and utilisation/cost data. 
Study quality and small study bias 
Table 4 shows the effects of self-management support on the three core outcomes, grouped 
according to risk of bias. Studies judged at high risk of bias reported greater benefits in health 
outcomes and greater reductions in hospitalization than those judged at low risk of bias, 
although they were also associated with increases in total costs. Table 5 shows the effects of 
self-management support on the three core outcomes, grouped according to country of origin 
(UK or other). The results suggest that studies in the UK demonstrated smaller effects on 
health outcomes. Conversely, studies in the UK demonstrated larger reductions in 
hospitalisation, but those were not matched by cost data, where UK studies showed a 
moderate increase in overall costs. 
Table 4 Overall effects by risk of bias 
 Overall effect size Effect size (high risk of bias) Effect size (low risk of bias) 
95% CI 95% CI 95% CI 
I2 I2 I2 
Health outcomes 0.22 (0.17 to 0.26) 0.23 (0.18 to 0.29) 0.18 (0.12 to 0.25) 
Hospital use −0.16 (−0.20 to −0.11) −0.18 (−0.24 to −0.11) −0.10 (−0.16 to −0.04) 
Costs 0.02 (−0.05 to 0.08) 0.07 (−0.05 to 0.18) −0.01 (−0.09 to -.07) 
Table 5 Overall effects by country 
 Overall effect size Effect size (UK studies) Effect size (Non UK studies) 
Health outcomes 0.22 0.10 0.25 
(0.17 to 0.26) (0.05 to 0.14) (0.19 to 0.30) 
Hospital use −0.16 −0.23 −0.14 
(−0.20 to −0.11) (−0.35 to −0.11) (−0.19 to −0.09) 
Costs 0.02 0.13 −0.04 
(−0.05 to 0.08) (0.02 to 0.24) (−0.12 to 0.04) 
The funnel plots for health outcomes (intercept 0.47, 95% CI −0.16 to 1.10, p = 0.14) (Figure 
4) and costs (intercept −0.46, 95% CI −1.71 to 0.79, p = 0.47) (Figure 5) did not show 
evidence of small study bias. The plot for hospital use (intercept −0.91, 95% CI −1.55 to 
−0.27, p = 0.01) did show evidence of small study bias (Figure 6). 
Figure 4 Funnel plot – Health outcomes. 
Figure 5 Funnel plot – Hospital use. 
Figure 6 Funnel plot – Total costs. 
  
Discussion 
In summary, self-management support interventions generally had a small but positive impact 
on health outcomes, with only a small minority of studies included in the review reporting 
decrements in outcomes in the permutation plots. In terms of the primary utilisation outcome 
of hospital use, the evidence was most robust in both scope and effect in relation to 
interventions in respiratory and cardiovascular problems. The magnitude of those effects was 
similar in cost outcomes. 
Strengths and limitations 
The study was conducted and reported in line with current guidance. The high number of 
included studies and the rapid timeframe of the review meant that we could not use 2 
independent researchers for all assessments and extraction, but we tested the reliability and 
found high levels of agreement. 
Designing searches and inclusion criteria for self-management is complex, because of the 
lack of consensus on the scope of the term. Our search was broad, but was dependent on the 
existence of key terms in the titles and abstracts. Additionally, it is not clear how the search 
terms for utilisation or other economic outcomes perform in terms of sensitivity or 
specificity, although they were tested against a known set of studies. We did not find 
evidence of publication bias in relation to health outcomes or costs, but there was evidence in 
terms of hospital use data. 
The broad scope of the review combined with the large number of studies meant that a less 
comprehensive quality assessment was used. This does mean that quality assessment was 
very dependent on the exact descriptions of concealment provided in the papers, and the more 
limited quality assessment may not be as reliable as a full risk of bias assessment. 
We required that data were reported in a way that was amenable to meta-analysis for cost and 
health outcomes. Such selection would potentially cause selection effects in the included 
studies. We were unable to formally test differences between eligible studies reporting or not 
reporting appropriate data, as data on the latter were not extracted because of resource 
limitations, and would by definition not have allowed assessment of variation in outcomes. 
Our aim (to identify studies that reduce costs while not compromising outcomes) reflects the 
current economic context faced by many commissioners of health care services, but does not 
map neatly onto current economic analyses, which focus on the incremental cost 
effectiveness ratio and net mean benefit. Self-management interventions which reduce costs 
without compromising outcomes might be attractive to commissioners, but so might 
interventions which increase costs, while providing significant additional health benefits. 
The most comprehensive assessment of costs would include all those related to the 
intervention (NHS services, social care and other costs, patient direct costs and costs of lost 
productivity). However, such comprehensive costing is rare, and more limited assessments of 
utilisation still have utility, as some forms of utilisation (such as hospital costs) are generally 
a major driver of total costs. However, caution must be exercised in interpretation of studies 
reporting partial cost data, as there is always the danger of cost shifting rather than genuine 
reduction (as evidenced in the comparison of Figures 2 and 3). Comprehensive costing will 
include the costs of the self-management intervention itself which is required to generate 
reductions in hospital use. 
Multimorbidity is prevalent among patients with long-term conditions, but a recent review of 
interventions found few studies [30], and our main analysis has been in terms of disease 
categories. It is possible that the results reported here could be significantly moderated by 
multimorbidity [31]. Our analysis assumed that self-management support is a ‘health 
technology’ which is potentially discrete, defined, and capable of being delivered in a 
standardised form. Clearly, many aspects of self-management are not of this type (such as 
that provided within social networks and informal care) [32], and these forms would have 
been excluded. 
Our analyses showed significant effects of self-management interventions for respiratory and 
cardiovascular diseases but failed to indicate clear effects for other long-term conditions. 
However, over half of the studies included in the review have been conducted among patients 
with these conditions. Failure to obtain clear results about the effects of self-management 
interventions on other conditions may partly reflects lack of power. 
We only explored basic moderators of effects (such as ‘self-management’ versus ‘case 
management’). There are a large number of factors on which studies differ, and it is possible 
in theory to use meta-regression techniques to explore the ‘active ingredients’ of 
interventions [33,34]. However, this is dependent on interventions with clearer boundaries 
and consensus over definitions. The range of self-management interventions included in the 
current review was very wide. When combined with inconsistent reporting, the utility of 
meta-regression is more limited. Similarly, the differences in Tables 4 and 5 should be 
interpreted with caution, as the associations with risk of bias and country of origin may be 
confounded by other differences between studies. 
Implications of the study for policy and practice 
As noted earlier, although many demand management interventions are focussed on high 
users of health care, many factors (such as the prevalence of high users, as well as artefacts 
such as regression to the mean) reduce the benefits of intervening in such groups [35]. Self-
management support thus has potential to make a large impact on utilisation, because it is 
relevant to so many patients with long-term conditions, but this assumes that it is (a) 
reductions in utilisation are achieved without compromising other outcomes (b) reductions in 
utilisation can be consistently achieved (c) self-management support can be disseminated 
widely. 
Our review suggests that very few self-management interventions compromise patient 
outcomes, at least among those populations consenting to take part in trials. Studies have 
suggested that self-management can lead to such reactions in some patients, particularly 
those with multimorbidity [36-38], but our data suggests that this is not a consistent outcome. 
The core issue thus relates to the impact of self-management support on reducing utilisation. 
Across conditions, the most robust effects (both in terms of number of studies, and the size of 
the effects) related to interventions in respiratory and cardiovascular patients, where there 
was a significant evidence base suggesting consistent (albeit small) reductions in hospital use 
and costs in both self-management interventions and case management, consistent with other 
reports in this area [39]. In terms of the wider implementation of self-management support, 
many trials were based on small, selected samples of volunteer patients, with isolated 
examples of attempts at more widespread implementation [40,41]. 
Understanding the limited and inconsistent impact of self-management requires examination 
of the assumptions underlying self-management as a demand management strategy. It is 
assumed that providing patients with self-management support will either lead to indirect 
utilisation benefits (where self-management leads to better health and thus reduces 
utilisation) or more direct effects (for example, where self-management enables more 
effective response to exacerbations and crises, avoiding high cost use such as hospital 
admission). 
There are a number of potential problems with these assumptions. Firstly, self-management 
interventions will vary in their explicit targeting of utilisation behaviour. As an example, self-
management plans to control exacerbations in respiratory disorders often has a core function 
to avoid unnecessary hospital use. In contrast, self-management in diabetes may have as its 
aim the patient empowerment and the improvement of diabetes control. Variation in impacts 
between conditions may reflect patterns of service delivery. For example, hospital use related 
to depression may be relatively rare compared to other conditions. There is also an 
assumption that utilisation behaviour is patient-led, but some utilisation (such as clinical 
attendance) may be led by professionals [42]. Health service innovations designed to manage 
demand may actually create supplier induced demand [35]. Many self-management 
interventions have fairly limited impacts health outcomes will set important limits on any 
indirect effects on utilisation, and even effective self-management interventions may not lead 
to enduring behaviour change. Few studies in the review assessed outcomes over greater than 
12 months, and modelling of long term economic consequences of improved health outcomes 
may be necessary. 
Implications of the study for research 
Analyses were hampered by poor reporting of outcome data. We adopted a simple coding of 
types of self-management interventions, but even assessments of the amount of professional 
support provided were often difficult. Few studies reported sufficient detail to allow 
assessment of issues which might impact on replicability of the interventions, especially 
around the sensitivity of the interventions to particular cultures or health care contexts. More 
consistent, comprehensive and theory-led reporting of interventions and outcomes would 
allow much more effective syntheses. 
Our analyses suggested that impacts of self-management support were patterned by type of 
long-term condition, but the utility of disease specific analyses may be limited in the context 
of increasing focus on multimorbidity. Patients with multiple conditions may face the biggest 
barriers to self-management [36], but may also have the greatest capacity to benefit [31]. 
Clearly, further primary research could usefully develop new models of self-management 
support that could achieve consistent effects on utilisation, following conventional models for 
the development of complex interventions [43] and drawing on relevant behavioural and 
social science models relating to patient experience of long-term conditions, as well as those 
relating to access to care and utilisation. 
There is also a need for a broader assessments of the value of self-management in the context 
of wider service redesign, as many models in this area highlight the interrelationships 
between patients, professionals, and the wider service context [13,44], which may be poorly 
modelled by conventional trials. 
Conclusions 
Self-management support interventions rarely compromised patient outcomes. There was 
evidence that self-management support interventions can reduce hospital use and total costs, 
although effects were generally small. Evidence for significant reductions in utilisation were 
strongest for interventions in respiratory and cardiovascular disorders. 
Reporting of data relevant to the core research question was poor. Research priorities relate to 
better reporting of the content of self-management support, exploration of the impact of 
multimorbidity, and assessment of factors influencing the wider implementation of self-
management support. 
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